Publications:

Efficient suppression of endogenous CFTR nonsense mutations using anticodon-engineered transfer RNAs.

Molecular Therapy. Nucleic Acids

Ko, Wooree W; Porter, Joseph J JJ; Sipple, Matthew T MT; Edwards, Katherine M KM; Lueck, John D JD

Publication Date: 2022-06-14

Variant appearance in text: CFTR: W1282L

PubMed Link: 35664697

Variant Present in the following documents:

• Main text
• mmc2.pdf
• main.pdf

View BVdb publication page

Nanomolar-potency 'co-potentiator' therapy for cystic fibrosis caused by a defined subset of minimal function CFTR mutants.

Scientific Reports

Phuan, Puay-Wah PW; Tan, Joseph-Anthony JA; Rivera, Amber A AA; Zlock, Lorna L; Nielson, Dennis W DW; Finkbeiner, Walter E WE; Haggie, Peter M PM; Verkman, Alan S AS

Publication Date: 2019-11-27

Variant appearance in text: CFTR: W1282L

PubMed Link: 31776420

Variant Present in the following documents:

• Main text
• 41598_2019_Article_54158.pdf

View BVdb publication page

Identification of the amino acids inserted during suppression of CFTR nonsense mutations and determination of their functional consequences.

Human Molecular Genetics

Xue, Xiaojiao X; Mutyam, Venkateshwar V; Thakerar, Amita A; Mobley, James J; Bridges, Robert J RJ; Rowe, Steven M SM; Keeling, Kim M KM; Bedwell, David M DM

Publication Date: 2017-08-15

Variant appearance in text: CFTR: W1282L

PubMed Link: 28575328

Variant Present in the following documents:

• Main text

View BVdb publication page